human gac cell lines kato iii (ATCC)
97
Structured Review
ATCC
human gac cell lines kato iii
Human Gac Cell Lines Kato Iii, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 734 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+gac+cell+lines+kato+iii/KATO+III/pm41677648-55-0-11
Average 97 stars, based on 734 article reviews
Human Gac Cell Lines Kato Iii, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 734 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+gac+cell+lines+kato+iii/KATO+III/pm41677648-55-0-11
Average 97 stars, based on 734 article reviews
human gac cell lines kato iii - by Bioz Stars,
2026-10
97/100 stars
Images
Related Articles
In Vitro:Article Title: Targeting the c-Met/VEGFR Pathway to Boost Nab -Paclitaxel Efficacy in Gastric Cancer: Preclinical Insights Article Snippet: The cell proliferation reagent WST-1 was purchased from Roche Diagnostics (Indianapolis, IN, USA), and RPMI 1640 growth medium was obtained from Sigma Chemical Corporation (St. Louis, MO, USA). Article Title: Targeting the c-Met/VEGFR Pathway to Boost Nab -Paclitaxel Efficacy in Gastric Cancer: Preclinical Insights. Article Snippet: The cell proliferation reagent WST-1 was purchased from Roche Diagnostics (Indianapolis, IN, USA), and RPMI 1640 growth medium was obtained from Sigma Chemical Corporation (St. Louis, MO, USA). Inhibition:Article Title: Targeting the c-Met/VEGFR Pathway to Boost Nab -Paclitaxel Efficacy in Gastric Cancer: Preclinical Insights Article Snippet: The cell proliferation reagent WST-1 was purchased from Roche Diagnostics (Indianapolis, IN, USA), and RPMI 1640 growth medium was obtained from Sigma Chemical Corporation (St. Louis, MO, USA). Article Title: Targeting the c-Met/VEGFR Pathway to Boost Nab -Paclitaxel Efficacy in Gastric Cancer: Preclinical Insights. Article Snippet: The cell proliferation reagent WST-1 was purchased from Roche Diagnostics (Indianapolis, IN, USA), and RPMI 1640 growth medium was obtained from Sigma Chemical Corporation (St. Louis, MO, USA). Incubation:Article Title: Targeting the c-Met/VEGFR Pathway to Boost Nab -Paclitaxel Efficacy in Gastric Cancer: Preclinical Insights Article Snippet: The cell proliferation reagent WST-1 was purchased from Roche Diagnostics (Indianapolis, IN, USA), and RPMI 1640 growth medium was obtained from Sigma Chemical Corporation (St. Louis, MO, USA). Article Title: Targeting the c-Met/VEGFR Pathway to Boost Nab -Paclitaxel Efficacy in Gastric Cancer: Preclinical Insights. Article Snippet: The cell proliferation reagent WST-1 was purchased from Roche Diagnostics (Indianapolis, IN, USA), and RPMI 1640 growth medium was obtained from Sigma Chemical Corporation (St. Louis, MO, USA). Concentration Assay:Article Title: Targeting the c-Met/VEGFR Pathway to Boost Nab -Paclitaxel Efficacy in Gastric Cancer: Preclinical Insights Article Snippet: The cell proliferation reagent WST-1 was purchased from Roche Diagnostics (Indianapolis, IN, USA), and RPMI 1640 growth medium was obtained from Sigma Chemical Corporation (St. Louis, MO, USA). Article Title: Targeting the c-Met/VEGFR Pathway to Boost Nab -Paclitaxel Efficacy in Gastric Cancer: Preclinical Insights. Article Snippet: The cell proliferation reagent WST-1 was purchased from Roche Diagnostics (Indianapolis, IN, USA), and RPMI 1640 growth medium was obtained from Sigma Chemical Corporation (St. Louis, MO, USA). Control:Article Title: Targeting the c-Met/VEGFR Pathway to Boost Nab -Paclitaxel Efficacy in Gastric Cancer: Preclinical Insights Article Snippet: The cell proliferation reagent WST-1 was purchased from Roche Diagnostics (Indianapolis, IN, USA), and RPMI 1640 growth medium was obtained from Sigma Chemical Corporation (St. Louis, MO, USA). Article Title: Targeting the c-Met/VEGFR Pathway to Boost Nab -Paclitaxel Efficacy in Gastric Cancer: Preclinical Insights. Article Snippet: The cell proliferation reagent WST-1 was purchased from Roche Diagnostics (Indianapolis, IN, USA), and RPMI 1640 growth medium was obtained from Sigma Chemical Corporation (St. Louis, MO, USA). |